secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001906324-26-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho reports FY25 revenue $2.73B, adjusted EBITDA $597M; guides FY26 revenue $2.7-2.9B
--------------------------------------------------------------------------------

- FY25 total revenue $2.73B in line with guidance; Labs revenue +6% as reported, non-respiratory +5% ex Donor Screening.
- GAAP net loss $1.13B includes $701M goodwill impairment; adjusted diluted EPS $2.12 (in range $2.00-$2.15).
- Adjusted EBITDA margin expanded 240 bps to 22%; adjusted EBITDA $597M (in range $585-$605M).
- FY26 guidance: revenue $2.7-2.9B, adjusted EBITDA $630-670M (23.3% margin), free cash flow $120-160M.
- Q4 revenue $724M, adjusted EBITDA $153M, adjusted EPS $0.46; Labs +8% as reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632426000003/0001906324-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632426000003/qdel-20260211.htm
  HTML page:      https://secwatch.observer/filing/0001906324-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer